首页> 外文期刊>Clinical oncology >Oral bisphosphonates, concurrent thoracic radiotherapy and oesophagitis.
【24h】

Oral bisphosphonates, concurrent thoracic radiotherapy and oesophagitis.

机译:口服双膦酸盐,并发胸腔放疗和食道炎。

获取原文
获取原文并翻译 | 示例
       

摘要

Sir - We wish to report the development of severe oesophagitis in a patient after palliative radiotherapy to the thoracic spine, while on oral bisphosphonates. A 67-year-old woman had a left mastectomy for breast carcinoma in 1996. Ten years later she developed chest wall recurrence, wliich was excised and treated with postoperative radiotherapy without complications. The patient was re-referred in December 2008 with thoracic spine discomfort. Investigations confirmed extensive bone metastases. Palliative radiotherapy was given in a single fraction to the thoracic spine from T7 to T10. A single posterior megavoltage (6MV) field was used with a dose of 12.5 Gy prescribed at D_(Max) (this is a long-established standard palliative regimen in this department [1]).
机译:主席先生-我们希望报告在接受口服双膦酸盐治疗后对胸椎进行姑息放疗后出现严重食管炎的情况。一名67岁的妇女于1996年因乳腺癌进行了左乳房切除术。十年后,她出现了胸壁复发,切除了wliich并接受了术后放疗,无并发症。该患者于2008年12月因胸椎不适而再次转诊。调查证实广泛的骨转移。从T7到T10对胸椎进行姑息放疗。使用单一的后兆电压(6MV)场,剂量为D_(Max)时指定的12.5 Gy(这是该部门历史悠久的标准姑息治疗方案[1])。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号